XML 24 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Assets    
Investments, at fair value: $ 1,954,270 [1] $ 1,760,030 [2]
Cash 8,415 82,739
Interest receivable on investments 36,724 26,526
Receivable due on investments sold and repaid 967 1,016
Dividends receivable on controlled investments 0 1,275
Prepaid expenses and other assets 1,348 825
Total assets 2,001,724 1,872,411
Liabilities    
Financing arrangements (net of unamortized debt issuance costs of $10,643 and $6,178, respectively) 1,081,701 951,322
Payable for investments purchased 4,692 0
Accounts payable and accrued expenses 1,036 1,012
Interest payable 10,231 7,820
Accrued management fees 6,893 6,924
Accrued subordinated incentive fee on income 4,615 5,065
Accrued administrative services expense 2,156 1,703
Shareholder distribution payable 10,837 14,931
Total liabilities 1,122,161 988,777
Commitments and contingencies (Note 4 and Note 11)
Shareholders' Equity    
Common stock, $0.001 par value; 500,000,000 shares authorized; 54,184,638 and 55,299,484 shares issued and 54,184,638 and 55,299,484 shares outstanding, respectively 54 55
Capital in excess of par value 1,033,030 1,044,547
Accumulated distributable losses (153,521) (160,968)
Total shareholders' equity 879,563 883,634
Total liabilities and shareholders' equity $ 2,001,724 $ 1,872,411
Net asset value per share of common stock at end of year (in dollars per share) [3] $ 16.23 $ 15.98
Non-controlled, non-affiliated investments    
Assets    
Investments, at fair value: $ 1,570,676 $ 1,525,040
Non-controlled, affiliated investments    
Assets    
Investments, at fair value: 206,301 143,876
Controlled investments    
Assets    
Investments, at fair value: $ 177,293 $ 91,114
[1] Fair value determined in good faith by the Company’s board of directors (see Note 9), including via delegation to CIM as the Company’s valuation designee (see Note 2), using significant unobservable inputs unless otherwise noted.
[2] Fair value determined in good faith by the Company’s board of directors (see Note 9), including via delegation to CIM as the Company’s valuation designee (see Note 2), using significant unobservable inputs unless otherwise noted.
[3] As discussed in Note 3, the Company completed a two-to-one reverse stock split, effective as of September 21, 2021. The shares outstanding used in the computation of net asset value per share for 2021 reflect the reverse stock split on a retroactive basis.